Early-life supplementation of Bifidobacterium infantis and 2’-fucosyllactose revives gut microbiota perturbation, intestinal development delay, and promotes immune function following the ceftriaxone challenge
Published: 15 November 2023| Version 1 | DOI: 10.17632/3h7v26pb94.1
Contributor:
雅亭 罗Description
This database contains body weight, colon crypt depth, intestinal Ki-67 ( + ) count, fecal bifidobacteria qPCR quantification, cecal short-chain fatty acids, spleen inflammatory factors, and antibody content determination results.
Files
Institutions
Sichuan University
Categories
Antibiotics, Probiotics, Milk Oligosaccharides
Funders
- National Natural Science Foundation of ChinaGrant ID: 81973042
- National Science Foundation for Young Scientists of ChinaGrant ID: 82003453, 82204037
- China Postdoctoral Science FoundationGrant ID: 2022M712228